非侵入性顱內壓監測設備市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、應用、地區和競爭對手分類，2021-2031年

全球非侵入性顱內壓 (ICP) 監測設備市場預計將從 2025 年的 4.1403 億美元成長到 2031 年的 5.9265 億美元，複合年成長率為 6.16%。

這些設備是無需手術或植入感測器即可測量顱內壓的診斷工具，它們採用視神經鞘超音波和經顱都卜勒等技術，能夠安全快速地評估腦脊髓液壓力。該市場的成長主要源於降低侵入性操作風險（例如感染和出血）的需求，以及對床邊監測（可實現神經重症監護中的早期療育）日益成長的需求。然而，與目前仍是臨床標準的侵入性腦室外引流相比，這些設備的準確性和可靠性面臨重大挑戰。數據準確性的差異性可能導致臨床醫生在做出關鍵治療決策時，對完全依賴非侵入性測量結果持謹慎態度。儘管如此，全球神經系統疾病盛行率的不斷上升仍在持續推動該領域的發展和需求。例如，世界衛生組織 (WHO) 報告稱，到 2025 年，全球超過 40% 的人口將受到神經系統疾病的影響，這表明迫切需要加強神經系統疾病的管理和診斷。

市場促進因素

全球非侵入性顱內壓監測設備市場的主要促進因素是全球創傷性腦損傷和中風發生率的不斷上升。頻繁進行顱內壓 (ICP) 評估的需求，以及臨床上傾向於採用無創技術來降低與有創腦室外引流相關的感染風險，共同推動了市場需求。神經系統疾病帶來的巨大經濟和臨床負擔凸顯了這項需求。例如，世界卒中組織估計，到 2025 年 1 月，全球每年因卒中造成的經濟損失將超過 8,900 億美元，凸顯了對有效且便於現場操作的解決方案的迫切需求。除了重症監護室 (ICU) 之外，由於人們越來越關注累積頭部損傷，該市場正在向小兒科和運動醫學領域擴展。美國疾病管制與預防中心 (CDC) 報告稱，到 2025 年 6 月，青少年運動和休閒相關腦震蕩的 12 個月盛行率將達到 7% 至 15%，這將為攜帶式診斷設備的更廣泛應用鋪平道路。同時，人工智慧（AI）在預測分析領域的應用正在提升這些設備的臨床效用。製造商正在開發能夠將生理波形與即時顱內壓（ICP）關聯起來的演算法，並利用機器學習來提高視神經鞘評估的準確性。這項技術進步對於縮小非侵入性工具與有創金標準之間的準確性差距至關重要。尤其值得一提的是，2025年12月，血管與介入性神經病學會（SVIN）將「SVIN創新獎」授予了一款全自動、人工智慧驅動的非侵入性ICP診斷工具。這表明，提高演算法的準確性對於增強臨床醫生的信心以及促進其在現代神經重症監護中的廣泛應用至關重要。

市場挑戰

全球非侵入性顱內壓監測設備市場成長面臨的主要挑戰是，與目前仍被視為臨床金標準的創腦室外引流術（EVD）相比，其準確性和可靠性相對較低。在神經重症監護領域，準確的顱內壓數據對於指導即時救命干預至關重要。非侵入性設備通常依賴間接的替代指標，因此更容易受到侵入性感測器所不具備的變異性影響。正因如此，臨床醫生往往認為這些非侵入性測量以金額為準不足以做出明確的治療決策，因此該技術主要局限於初步篩檢，而非核心監測設備。這種臨床上的質疑嚴重阻礙了市場滲透，尤其是在需要精準管理的重症監護環境中。複雜神經系統疾病的高發生率凸顯了由於這些表現差距而造成的市場潛力損失。例如，美國中樞腦腫瘤登記處預測，到 2025 年，美國將新增約 107,100 例惡性和非惡性腦腫瘤及其他中樞神經系統腫瘤病例。在如此大規模的患者群體中，非侵入性系統無法與侵入性方法的精確度相媲美，這一事實有效地將其排除在主要診斷流程之外，直接限制了市場擴張。

市場趨勢

無線和穿戴式監測技術的出現正在改變市場格局，將顱內壓評估從間歇性測量轉變為連續、非侵入性監測。這些創新的穿戴式感測器，包括顱骨應變計，能夠檢測顱骨因壓力變化而產生的細微擴張，從而實現在各種臨床環境下對患者進行長期觀察，這與將患者連接到床邊監護儀的傳統方法截然不同。這種連續監測能力對於檢測常規檢查中可能遺漏的瞬時壓力升高至關重要，即使在重症監護室之外，也能提高病患的安全。為了支持這項轉變，Brain4Care公司於2025年4月發布的《Brain4Care系統臨床表現》報告顯示，其無創穿戴式平台在檢測顱內高壓方面達到了92%的靈敏度，無需進行侵入性操作即可有效排除高血壓疾病。同時，光學和超音波技術的進步正在建立標準化、快速的診斷方案，其效果可與侵入性黃金標準相媲美。例如，先進的視神經鞘直徑（ONSD）超音波技術已發展成為一種可靠的床邊（POC）工具，可為神經重症監護和緊急情況下的分流提供即時且可操作的數據，尤其是在無法進行或不宜進行侵入性操作的情況下。這些進步正在用客觀、可量化的指標取代主觀評估，推動其在臨床實踐中更廣泛的應用。例如，世界神經外科協會聯盟（WFNS）於2025年3月發布的《B-ICONIC共識洞察》報告明確指出，ONSD 6毫米是顱內壓升高的閾值，為指導快速治療性介入提供了一致的參考標準。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：非侵入性顱內壓監測設備的全球市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 檢查類型（經顱都卜勒超音波、鼓膜移位（TMD）、視神經鞘直徑、MRI/CT、其他）
  • 依應用領域（創傷性腦損傷、腦出血、腦膜炎、蜘蛛網膜下腔出血等）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美無創顱內壓監測設備市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲非侵入性顱內壓監測設備市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區非侵入性顱內壓監測設備市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲無創顱內壓監測設備市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲無創顱內壓監測設備市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球無創顱內壓監測設備市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Medtronic plc
• Raumedic AG
• Integra LifeSciences Holdings Corporation
• Spiegelberg GmbH & Co. KG
• Natus Medical Incorporated
• Siemens Healthineers AG
• Sophysa SA
• NeuroWave Systems Inc.
• HeadSense Medical Ltd.
• BrainScope Company, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

The global market for non-invasive intracranial pressure (ICP) monitoring devices is expected to expand from USD 414.03 million in 2025 to USD 592.65 million by 2031, exhibiting a compound annual growth rate (CAGR) of 6.16%. These devices are diagnostic tools that measure pressure inside the skull without surgical intervention or sensor insertion, employing technologies like optic nerve sheath diameter ultrasonography and transcranial Doppler for safe and rapid cerebrospinal fluid pressure assessment. This market growth is driven by the necessity to reduce risks associated with invasive procedures, such as infection and hemorrhage, and a rising demand for bedside monitoring that enables early intervention in neurocritical care. Nevertheless, the sector confronts a major hurdle in the form of these devices' accuracy and reliability compared to invasive external ventricular drains, which are still considered the clinical benchmark. Data precision inconsistencies can make clinicians hesitant to depend exclusively on non-invasive measurements for crucial treatment decisions. Despite this, the increasing global prevalence of neurological disorders continues to fuel both development and demand; for instance, the World Health Organization reported that neurological conditions impacted over 40% of the global population in 2025, indicating a vast need for enhanced neurological management and diagnostics.

Market Driver

The primary driver for the Global Non-invasive Intracranial Pressure Monitoring Devices Market is the escalating worldwide occurrence of traumatic brain injuries and stroke. The need for frequent ICP assessment, coupled with a clinical preference for non-invasive methods to mitigate infection risks linked to invasive external ventricular drains, boosts demand. This necessity is highlighted by the significant economic and clinical burden of neurological conditions; for example, the World Stroke Organization estimated the global annual cost of stroke to surpass US$890 billion in January 2025, emphasizing the urgent need for effective, point-of-care management solutions. Beyond the ICU, the market is also expanding into pediatric and sports environments due to increasing concerns about cumulative head trauma, with the Centers for Disease Control and Prevention reporting a 12-month prevalence of 7% to 15% for sports- and recreation-related concussions in youth in June 2025, paving the way for wider adoption of portable diagnostics. Simultaneously, the incorporation of artificial intelligence for predictive analytics is improving the clinical utility of these devices, as manufacturers utilize machine learning to enhance the precision of optic nerve sheath assessments by developing algorithms that correlate physiological waveforms with real-time ICP. This technological progress is crucial for narrowing the accuracy disparity between non-invasive tools and the invasive gold standard; notably, in December 2025, the Society of Vascular and Interventional Neurology awarded its SVINnovation prize to an AI-powered, fully automated non-invasive ICP diagnostic tool, showcasing how advancements in algorithmic accuracy are essential for fostering clinician trust and widespread deployment in modern neurocritical care.

Market Challenge

The principal challenge impeding the growth of the Global Non-invasive Intracranial Pressure Monitoring Devices Market is their relative deficiency in accuracy and reliability compared to invasive external ventricular drains (EVDs), which remain the clinical gold standard. In neurocritical care, precise ICP data is indispensable for guiding immediate, life-saving interventions. Non-invasive devices, which often rely on indirect surrogate markers, are susceptible to variations not present in invasive sensors. As a result, clinicians often perceive these non-invasive measurements as inadequate for informing definitive therapeutic decisions, thus confining the technology primarily to a preliminary screening function rather than a core monitoring instrument. This clinical skepticism substantially hampers market penetration, especially in critical care scenarios where precise management is crucial. The significant prevalence of complex neurological pathologies highlights the untapped market potential lost due to these performance discrepancies. For instance, the Central Brain Tumor Registry of the United States projected approximately 107,100 new cases of malignant and non-malignant brain and other central nervous system tumors in the US in 2025. For such a large patient population, the inability of non-invasive systems to match the precision of invasive methods effectively excludes them from the primary diagnostic workflow, directly constraining market expansion.

Market Trends

The market is undergoing a significant transformation with the advent of wireless and wearable monitoring technologies, shifting intracranial pressure assessment from intermittent measurements to continuous, non-invasive surveillance. These innovative wearable sensors, including cranial strain gauges, identify subtle skull expansions linked to pressure changes, facilitating extended patient observation in various clinical settings, unlike traditional methods that tether patients to bedside monitors. This continuous monitoring capability is vital for detecting transient pressure spikes frequently missed by periodic checks, thereby improving patient safety beyond the ICU. Supporting this shift, Brain4Care's "Clinical Performance of the Brain4care System" report in April 2025 indicated that their non-invasive wearable platform achieved 92% sensitivity in detecting intracranial hypertension, effectively ruling out elevated pressure without invasive procedures. Concurrently, advancements in optical and ultrasound-based techniques are leading to standardized, rapid diagnostic protocols that can compete with invasive gold standards. For instance, advanced ultrasonography of the optic nerve sheath diameter (ONSD) has evolved into a dependable point-of-care tool, delivering immediate, actionable data for triage in neurocritical care and emergency situations where invasive procedures are not feasible or available. This progress is fostering wider clinical adoption by replacing subjective evaluations with objective, quantified metrics. As evidence, the World Federation of Neurosurgical Societies' "Insights from the B-ICONIC Consensus" report in March 2025 established a clear ONSD threshold of 6 mm as an indicator of elevated intracranial pressure, providing a consistent metric for guiding prompt therapeutic interventions.

Key Market Players

• Medtronic plc
• Raumedic AG
• Integra LifeSciences Holdings Corporation
• Spiegelberg GmbH & Co. KG
• Natus Medical Incorporated
• Siemens Healthineers AG
• Sophysa SA
• NeuroWave Systems Inc.
• HeadSense Medical Ltd.
• BrainScope Company, Inc.

Report Scope

In this report, the Global Non-invasive Intracranial Pressure Monitoring Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Non-invasive Intracranial Pressure Monitoring Devices Market, By Type

• Transcranial Doppler Ultrasonography
• Tympanic Membrane Displacement (TMD)
• Optic Nerve Sheath Diameter
• MRI/CT
• Others

Non-invasive Intracranial Pressure Monitoring Devices Market, By Application

• Traumatic Brain Injury
• Intracerebral Hemorrhage
• Meningitis
• Subarachnoid Hemorrhage
• Others

Non-invasive Intracranial Pressure Monitoring Devices Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Non-invasive Intracranial Pressure Monitoring Devices Market.

Available Customizations:

Global Non-invasive Intracranial Pressure Monitoring Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Non-invasive Intracranial Pressure Monitoring Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Transcranial Doppler Ultrasonography, Tympanic Membrane Displacement (TMD), Optic Nerve Sheath Diameter, MRI/CT, Others)
  • 5.2.2. By Application (Traumatic Brain Injury, Intracerebral Hemorrhage, Meningitis, Subarachnoid Hemorrhage, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Non-invasive Intracranial Pressure Monitoring Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application

7. Europe Non-invasive Intracranial Pressure Monitoring Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
  • 7.3.2. France Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application

8. Asia Pacific Non-invasive Intracranial Pressure Monitoring Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application

9. Middle East & Africa Non-invasive Intracranial Pressure Monitoring Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
  • 9.3.2. UAE Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
  • 9.3.3. South Africa Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application

10. South America Non-invasive Intracranial Pressure Monitoring Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Colombia Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
  • 10.3.3. Argentina Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Non-invasive Intracranial Pressure Monitoring Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic plc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Raumedic AG
• 15.3. Integra LifeSciences Holdings Corporation
• 15.4. Spiegelberg GmbH & Co. KG
• 15.5. Natus Medical Incorporated
• 15.6. Siemens Healthineers AG
• 15.7. Sophysa SA
• 15.8. NeuroWave Systems Inc.
• 15.9. HeadSense Medical Ltd.
• 15.10. BrainScope Company, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer